Memantine for Fragile X-associated Tremor/Ataxia Syndrome (FXTAS): A Randomized, Double-Blind, Placebo-Controlled Trial

OBJECTIVE: Memantine, an NMDA receptor uncompetitive antagonist, is currently approved by the Food and Drug Administration for the treatment of moderate to severe Alzheimer’s disease. Anecdotal reports have suggested that memantine may improve neurological and cognitive symptoms of individuals with...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Psychiatry
Main Authors: Seritan, Andreea L., Nguyen, Danh V., Mu, Yi, Tassone, Flora, Bourgeois, James A., Schneider, Andrea, Cogswell, Jennifer, Cook, Kylee, Leehey, Maureen, Grigsby, Jim, Olichney, John M., Adams, Patrick, Legg, Wendi, Zhang, Lin, Hagerman, Paul, Hagerman, Randi J.
Format: Artigo
Sprog:Inglês
Udgivet: 2014
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4296896/
https://ncbi.nlm.nih.gov/pubmed/24345444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.13m08546
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker